Wearable Device to Treat Brain Cancer by Using Electrical Stimulation Medically reviewed by Brigid Dwyer, MD Optune is a ...

Celgene aims to boost the effectiveness of its novel drug marizomib for aggressive brain tumour glioblastoma (GBM) by asking patients to wear a special cap. Marketed by Novocure, the Optune ...

Novocure has launched Optune, its first TTFields delivery system, for the treatment of glioblastoma multiforme and potentially other solid tumor indications. For over 100 years, surgery ...

Then my radiation oncologist asked if I’d be interested in trying a medical device called Optune® for the treatment of glioblastoma multiforme (GBM) and walked me through the risks and benefits.

The results are the most significant increases in both survival rates reported in a phase 3 trial for newly diagnosed GBM. Median overall survival was also improved in the Optune plus ...

Doctors diagnosed Ivan with Glioblastoma, aggressive brain cancer. "Now we're facing this monster and we're going to do whatever it takes to get rid of it," Del Valle said.

In 2024, we brought Optune Gio ® to more than 4,000 glioblastoma patients across the globe, earned FDA approval and launched Optune Lua ® in non-small cell lung cancer in the U.S., announced two ...

CEO Ashley Cordova said: “In 2024, we brought Optune Gio to more than 4,000 glioblastoma patients across the globe, earned FDA approval and launched Optune Lua in non-small cell lung cancer in ...